QUICK SEARCH:   [advanced]
Author:
Keyword(s):
Year:  Vol:  Page: 

   

 

Health Affairs, 23, no. 1 (2004): 218-226
doi: 10.1377/hlthaff.23.1.218
© 2004 by Project HOPE
 
New Online
 * McAllen, TX & Beyond: An Expert Roundtable
 * Geography & Reform
 * Medicaid or Insurance Exchange?
 * Siren Song of New GME
 * Public Plan Option: Pro & Con
This Article
* Full Text (HTML)
* Reprint (PDF)
* Submit a response to this article
* Alert me when this article is cited
* Alert me when Comments are posted
* Alert me if a correction is posted
Services
* E-mail this article to a friend
* Similar articles in this journal
* Similar articles in ISI Web of Science
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Personal Archive
* Download to Citation Manager
*Reprints & Permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via ISI Web of Science (6)
* Citing Articles via Google Scholar
Google Scholar
* Articles by Landon, B. E.
* Articles by Blumenthal, D.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Landon, B. E.
* Articles by Blumenthal, D.
Related Collections
* Insurance Coverage
* Pharmaceuticals
* Physicians

DataWatch

Physicians’ Views Of Formularies: Implications For Medicare Drug Benefit Design

Bruce E. Landon, James D. Reschovsky and David Blumenthal

As Congress considers introducing a drug benefit for Medicare, it will more than likely adopt a program that uses a formulary. We examined data from the Community Tracking Study Physicians Survey, a large, nationally representative study of physicians, to learn about physicians’ views of formularies. Our results suggest that several aspects of formularies are associated with physicians’ positive views about them. Policymakers should consider imposing limits on the number of competing Medicare formularies operating in a particular area, promoting the adoption and use of information technology, and incorporating financial incentives for physicians to adhere to formularies.


Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati    What's this?


This article has been cited by other articles:


Home page
JAMAHome page
C.-W. Tseng, C. M. Mangione, R. H. Brook, E. Keeler, and R. A. Dudley
Identifying Widely Covered Drugs and Drug Coverage Variation Among Medicare Part D Formularies
JAMA, June 20, 2007; 297(23): 2596 - 2602.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
H. H. Pham, G. C. Alexander, and A. S. O'Malley
Physician Consideration of Patients' Out-of-Pocket Costs in Making Common Clinical Decisions
Arch Intern Med, April 9, 2007; 167(7): 663 - 668.
[Abstract] [Full Text] [PDF]


Home page
Health Aff (Millwood)Home page
C. Koyanagi, S. Forquer, and E. Alfano
Medicaid Policies To Contain Psychiatric Drug Costs
Health Aff., March 1, 2005; 24(2): 536 - 544.
[Abstract] [Full Text] [PDF]



Home | Current Issue | Archives | Topic Collections | Search | Blog | Subscribe | Contact Us | Help

© 2001-2004 Project HOPE–The People-to-People Organization
Terms and Policies